##  [Share ownership](/investors/share-data-and-analysis/share-ownership "Share ownership") 

 The following tables relate only to registered shareholders and cannot be assumed to represent the entire investor base because nominees and JPMorgan Chase Bank, N.A., as ADS depositary, are registered as shareholders for a large number of beneficial owners.

As at December 31, 2025, Novartis AG had approximately 184 000 registered shareholders.

## Registered shareholders by type

As at December 31, 2025Shareholders in %Shares in %Individual shareholders97.0019.49Legal entities12.9841.12Nominees and fiduciaries0.0239.39## Registered shareholders by country2

As at December 31, 2025Shareholders in %Shares in %Belgium0.102.96Canada0.030.71France2.120.51Germany5.971.86Ireland0.620.80Luxembourg0.061.28Sweden0.090.56Switzerland182.5552.22United Kingdom0.7310.82United States0.2325.74Other countries7.502.54

 



 

 

 

 

1 Excluding 9.6% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries (including Swiss foundations controlled by Novartis AG)  
2 Registered shares held by nominees are shown in the country where the company/affiliate entered in the Share Register as shareholder has its registered office.